ZAVICEFTA 2/0.5GM VIAL 1'S

While taking ZAVICEFTA 2/0.5GM VIAL 1'S, drinking adequate fluids, such as water, is generally recommended to support kidney function and prevent dehydration.

Yes, like other antibiotics, ZAVICEFTA 2/0.5GM VIAL 1'S can cause allergic reactions in some individuals. If you experience symptoms such as rash, itching, swelling, severe dizziness, or difficulty breathing, seek immediate medical attention.

ZAVICEFTA 2/0.5GM VIAL 1'S is usually administered through intravenous (IV) infusion. The duration and dosage of treatment are based on the type and severity of the infection and the patient's specific medical condition. The administration is done in a healthcare setting, such as a hospital.

ZAVICEFTA 2/0.5GM VIAL 1'S is primarily used to treat complicated urinary tract infections (cUTIs), including pyelonephritis (kidney infection) and complicated intra-abdominal infections (cIAIs). It may also treat hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP).

Ceftazidime is a cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Avibactam is a beta-lactamase inhibitor. Avibactam helps protect Ceftazidime from being degraded by beta-lactamase enzymes, allowing the antibiotic to kill the bacteria effectively.

You should inform your doctor about all medications, supplements, and herbal products you are taking to check for potential interactions with ZAVICEFTA 2/0.5GM VIAL 1'S.

Yes, it is important to finish the entire prescribed course of ZAVICEFTA 2/0.5GM VIAL 1'S, even if you start feeling better. Stopping early can lead to incomplete treatment and resistant infections.

Notify your doctor if you have allergies to cephalosporin antibiotics, penicillins, or other medications. Also, report any adverse reactions or side effects you experience during treatment with ZAVICEFTA 2/0.5GM VIAL 1'S.

ZAVICEFTA 2/0.5GM VIAL 1'S contains the active ingredients Ceftazidime and Avibactam.

ZAVICEFTA 2/0.5GM VIAL 1'S is used to treat various serious bacterial infections, such as complicated urinary tract infections (including kidney infections), complicated intra-abdominal infections, and hospital-acquired pneumonia.